(A) Plasma (no deficits at discharge, n=138 and deficits at discharge, n=79; no deficits at 6-months follow-up, n=198 and deficits at 6-months follow-up, n=11) and (B) CSF TNF-α (no deficits at discharge, n=93 and deficits at discharge, n=63; no deficits at 6-months follow-up, n=141 and deficits at 6-months follow-up, n=10) at enrollment based on neurologic outcomes at discharge or 6-months follow-up (values on a logarithmic scale). The horizontal line represents median values. Two-sample Wilcoxon rank-sum (Mann-Whitney) test was used to compare median levels between groups.